Correlates of In-Program Substance Use Trajectory Groups in Drug Treatment Courts

Abstract

Drug treatment courts (DTCs) offer a community-based alternative sanction that prioritizes combining substance use treatment and judicial oversight to support the recovery of system-involved individuals who have substance use issues. While the goal of treatment is to curb participants’ propensity to use substances, treatment impact may vary in participant relapse in this setting. The current study utilized official DTC records (N = 320) from a southwestern program across 10 years to identify program and individual characteristics associated with substance use patterns during the first 90 days of admission. Using group-based trajectory modeling, three in-program substance use group trajectories emerged: abstainers, non-responders, and responders. Analysis of variance and post hoc tests revealed that poor overall program compliance across multiple DTC components was correlated with trajectory group membership. Thus, the findings indicate that adherence to some program requirements may influence in-program substance use. Policy implications and future research directions for improving DTC efficacy for subgroups are discussed.

Keywords

substance use drug treatment court risk factors trajectory groups community corrections

Get full access to this article

View all access options for this article.

References

Andrews

D. A.

Bonta

Wormith

J. S.

(2006). The recent past and near future of risk and/or need assessment. Crime and Delinquency, 52(1), 7–27.

Banks

Gottfredson

D. C.

(2003). The effects of drug treatment and supervision on time to rearrest among drug treatment court participants. Journal of Drug Issues, 33(2), 385–412. https://doi.org/10.1177/002204260303300206

Barton

(2007). Baltimore City Drug Treatment Court: Process Evaluation. NPC Research.

Bonta

Andrews

D. A.

2007). Risk-need-responsivity model of offender assessment and rehabilitation. Public Safety Canada.

Brown

R. T.

(2010). Systematic review of the impact of adult drug treatment courts. Translational Research, 155(6), 263–274. https://doi.org/10.1016/j.trsl.2010.03.001

Brown

R. T.

Allison

P. A.

Nieto

F. J.

(2011). Impact of jail sanctions during drug court participation upon substance abuse treatment completion. Addiction, 106(1), 135–142. https://doi.org/10.1111/j.1360-0443.2010.03102.x

Butzin

C. A.

Saum

C. A.

Scarpitti

F. R.

(2002). Factors associated with completion of a drug treatment court diversion program. Substance Use and Misuse, 37(12–13), 1615–1633. https://doi.org/10.1081/JA-120014424

DeMatteo

Marlowe

D. B.

Festinger

D. S.

Arabia

P. L.

(2009). Outcome trajectories in drug court: Do all participants have serious drug problems? Criminal Justice and Behavior, 36(4), 354–368. https://doi.org/10.1177/0093854809331547

Drug Courts Program Office. (2004). Defining drug courts: The key components (National Criminal Justice Reference No. NCJ 205621). Office of Justice Programs. (Original work published 1997).

10.

Gallagher

J. R.

(2014). Predicting criminal recidivism following drug court: Implications for drug court practice and policy advocacy. Journal of Addictions and Offender Counseling, 35(1), 15–29. https://doi.org/10.1002/j.2161-1874.2014.00021.x

11.

Gallagher

J. R.

Nordberg

Deranek

M. S.

Ivory

Carlton

Miller

J. W.

(2015). Predicting termination from drug court and comparing recidivism patterns: Treating substance use disorders in criminal justice settings. Alcoholism Treatment Quarterly, 33(1), 28–43. https://doi.org/10.1080/07347324.2015.982451

12.

Gibbs

B. R.

Lytle

(2020). Drug court participation and time to failure: An examination of recidivism across program outcome. American Journal of Criminal Justice, 45, 215–235. https://doi.org/10.1007/s12103-019-09498-0

13.

Goldkamp

J. S.

White

M. D.

Robinson

J. B.

(2001). Do drug courts work? Getting inside the drug court black box. Journal of Drug Issues, 31(1), 27–72. https://doi.org/10.1177/002204260103100104

14.

Gottfredson

D. C.

Kearley

B. W.

Najaka

S. S.

Rocha

C. M.

(2007). How drug treatment courts work: An analysis of mediators. Journal of Research in Crime and Delinquency, 44(1), 3–35. https://doi.org/10.1177/0022427806291271

15.

Halliday-Boykins

C. A.

Schaeffer

C. M.

Henggeler

S. W.

Chapman

J. E.

Cunningham

P. B.

Randall

Shapiro

S. B.

(2010). Predicting nonresponse to juvenile drug court interventions. Journal of Substance Abuse Treatment, 39(4), 318–328. https://doi.org/10.1016/j.jsat.2010.07.011

16.

Hepburn

J. R.

Harvey

A. N.

(2007). The effect of the threat of legal sanction on program retention and completion: Is that why they stay in drug court? Crime & Delinquency, 53(2), 255–280. https://doi.org/10.1177/0011128705283298

17.

Hiller

Belenko

Taxman

Young

Perdoni

Saum

(2010). Measuring drug court structure and operations: Key components and beyond. Criminal Justice and Behavior, 37(9), 933–950. https://doi.org/10.1177/0093854810373727

18.

Jones

C. G.

Kemp

R. I.

(2011). The relationship between early-phase substance-use trajectories and drug court outcomes. Criminal Justice and Behavior, 38(9), 913–933. https://doi.org/10.1177/0093854811411887

19.

Lovins

L. B.

Tillyer

M. S.

Lovins

B. K.

Tillyer

May

(2024). An empirical approach to a standard practice: Drug testing. Crime and Delinquency, 70(8), 2017–2042. https://doi.org/10.1177/00111287221125389

20.

Lurigio

A. J.

(2008). The first 20 years of drug treatment courts: A brief description of their history and impact. Federal Probation, 72(1), 13–17. https://www.uscourts.gov/about-federal-courts/probation-and-pretrial-services/federal-probation-journal/2008/06/first-20-years-drug-treatment-courts-a-brief-description-their-history-and-impact

21.

Matusow

Dickman

S. L.

Rich

J. L.

Fong

Dumont

D. M.

Hardin

Marlowe

Rosenblum

(2013). Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes. Journal of Substance Abuse Treatment, 44(5), 473–480. https://doi.org/10.1016/j.jsat.2012.10.004

22.

Mikolajewski

A. J.

Allan

N. P.

Merrill

Carter

M. C.

Manguno-Mire

(2021). Employing the risk-need-responsivity (RNR) model and predicting successful completion in an alternative drug court program: Preliminary findings from the Orleans Parish drug court. Journal of Substance Abuse Treatment, 131, 108453. https://doi.org/10.1016/j.jsat.2021.108453

23.

Nagin

(2005). Group-based modeling of development. Harvard University Press.

24.

Newton-Taylor

Patra

Gliksman

(2009). Toronto drug treatment court: Participant intake characteristics as predictors of “successful” program completion. Journal of Drug Issues, 39(4), 965–987. https://doi.org/10.1177/002204260903900410

25.

Paik

(2006). Organizational interpretations of drug test results. Law and Society Review, 40(4), 931–962. https://doi.org/10.1111/j.1540-5893.2006.00286.x

26.

Peters

R. H.

Young

M. S.

Rojas

E. C.

Gorey

C. M.

(2017). Evidence-based treatment and supervision practices for co-occurring mental and substance use disorders in the criminal justice system. The American Journal of Drug and Alcohol Abuse, 43(4), 475–488. https://doi.org/10.1080/00952990.2017.1303838

27.

Randall-Kosich

Whitaker

D. J.

Guastaferro

W. P.

Rivers

(2022). Predicting drug court graduation: Examining the role of individual and programmatic characteristics. Journal of Substance Abuse Treatment, 135, 108654.

28.

Shaffer

D. K.

(2011). Looking inside the black box of drug courts: A meta-analytic review. Justice Quarterly, 28(3), 493–521. https://doi.org/10.1080/07418825.2010.525222

29.

Shannon

L. M.

Jackson Jones

Perkins

Newell

Neal

(2016). Examining individual factors and during-program performance to understand drug court completion. Journal of Offender Rehabilitation, 55(5), 271–292. https://doi.org/10.1080/10509674.2016.1181130

30.

Shannon

L. M.

Jones

A. J.

Newell

Nichols

(2020). Examining predisposing factors and program performance indicators associated with program completion: A comparison of opioid and non-opioid-preferring participants in drug court. International Journal of Offender Therapy and Comparative Criminology, 64(12), 1236–1257. https://doi.org/10.1177/0306624X19866130

31.

Simpson

D. D.

(1979). The relation of time spent in drug abuse treatment to posttreatment outcome. The American Journal of Psychiatry, 136(11), 1449–1453. https://doi.org/10.1176/ajp.136.11.1449

32.

Simpson

D. D.

Joe

G. W.

Brown

B. S.

(1997). Treatment retention and follow-up outcomes in the drug abuse treatment outcome study (DATOS). Psychology of Addictive Behaviors, 11(4), 294–307. https://doi.org/10.1037/0893-164X.11.4.294

33.

Taxman

F. S.

Bouffard

J. A.

(2005). Treatment as part of drug court: The impact on graduation rates. Journal of Offender Rehabilitation, 42(1), 23–50. https://doi.org/10.1300/J076v42n01_02

34.

Wasserman

(2000). Bayesian Model selection and model averaging. Journal of Mathematical Psychology, 44(1), 92–107. https://doi.org/10.1006/jmps.1999.1278

35.

Zettler

H. R.

(2018). Exploring the relationship between dual diagnosis and recidivism in drug court participants. Crime and Delinquency, 64(3), 363–397. https://doi.org/10.1177/0011128717697960